Evidence for an Intrahepatic Contribution to the Waning Effect of Glucagon on Glucose Production in the Conscious Dog
The DOI matches its Crossref record.
Abstract
We previously showed that infusion of glucagon at four times the basal rate into conscious dogs given somatostatin and basal replacement amounts of insulin caused hyperglycemia (217 ± 15 mg/dl) for at least 3 h and an initial increment in hepatic glucose production of 5.5 ± 0.8 mg/kg · min. After 3 h, however, the effect of hyperglucagonemia on glucose production had declined by 85%. The aim of the present study was to determine the importance of hyperglycemia in the “downregulation” of the action of glucagon. Six overnight-fasted conscious dogs were given somatostatin (0.8 μg/kg · min) plus basal intraportal replacement amounts of insulin (263 μU/kg · min) and glucagon (0.65 ng/kg · min). Hyperglycemia (276 ± 12 md/dl) was established after 2 h by the infusion of exogenous glucose. The glucagon infusion rate was then increased fourfold 1 h later, so that the plasma glucagon level rose from 95 ± 16 to 227 ± 35 pg/ml. The glucose concentration was maintained at a fixed value despite the increase in glucagon by decreasing the glucose infusion rate by an amount equal to the increase in endogenous glucose production induced by the hormone. Glucose production was measured using a primed infusion of 3H-glucose. With the insulin (11 ± 2 μU/ml) and glucose levels fixed, the elevation in glucagon caused an initial increment of 5.1 ± 0.7 mg/kg · min in glucose production which was followed by a fall of only 2.5 · 0.4 mg/kg · min (50%) over the next 3 h. Thus, when the plasma glucagon level is raised fourfold under conditions in which insulin mobilization cannot occur, the effect of hyperglucagonemia on glucose production will be partially offset by the resulting hyperglycemia and partly inhibited by an hepatic factor(s).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus
Epstein, F. H., Cryer, P. E., & Gerich, J. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507253130405 · Cited by 273
Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM
Dinneen, S., Alzaid, A., Turk, D., & Rizza, R. (1995) · Diabetologia · doi:10.1007/bf00400639 · Cited by 190
“Previous studies have shown that stimulation of glycogenolysis by glucagon appears to be transient since hepatic glucose release returns toward baseline despite continued hyperglucagonaemia [22-24].”
BackgroundCompartmental modeling of glucagon kinetics in the conscious dog
Dobbins, R. L., Davis, S. N., Neal, D. W., Cobelli, C., Jaspan, J., & Cherrington, A. D. (1995) · Metabolism · doi:10.1016/0026-0495(95)90051-9 · Cited by 72
Self-citationThe Prevention and Correction of Hypoglycemia
Cryer, P. E. (2001) · Comprehensive Physiology · doi:10.1002/cphy.cp070235 · Cited by 23
Coate, K. C., Ramnanan, C. J., Smith, M., Winnick, J. J., Kraft, G., Irimia-Dominguez, J., Farmer, B., Donahue, E. P., Roach, P. J., Cherrington, A. D., et al. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00316.2023 · Cited by 7
Self-citation
Metadata
- Authors
- Cherrington, A. D., Diamond, M. P., Green, D. R., & Williams, P. E.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1982-10-01
- Volume
- 31
- Issue
- 10
- Pages
- 917-922
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2078452457
- Cited by
- 35
- References
- 0
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evidence for an Intrahepatic Contribution to the Waning Effect of Glucagon on Glucose Production in the Conscious Dog. https://app.cochat.ai/papers/10.2337/diab.31.10.917
- The paper
- Cherrington, A. D., Diamond, M. P., Green, D. R., & Williams, P. E. (1982). Evidence for an Intrahepatic Contribution to the Waning Effect of Glucagon on Glucose Production in the Conscious Dog. Diabetes. https://doi.org/10.2337/diab.31.10.917
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.